Literature DB >> 7320434

Endemic cretinism in Sicily.

S Squatrito, F Delange, F Trimarchi, E Lisi, R Vigneri.   

Abstract

This work reports the presence of endemic cretinism in a small district located inside an endemic goiter area in north-eastern Sicily, personally described. The study covers 19 mental defectives (11 females and 8 males, mean age 35.8 +/- 15.5 yr) selected on the basis of severe mental retardation recognized by the local doctors. No systematic survey for cretinism was carried out in the total population. Marked mental retardation was evident in all subjects. Nine of them exhibited clinical and biochemical signs of hypothyroidism (myxedematous cretins). The 10 others were clinically euthyroid and had deaf-mutism and/or pyramidal tract dysfunction (neurological cretinism). Familial aggregation of cretinism was also observed. In both myxedematous and neurological cretins and urinary iodine excretion was very low, but not significantly different from that recorded in the euthyroid controls of the same area. The data available do not clarify the pathogenesis of endemic cretinism in Sicily. However, the marked height retardation, the observation of delayed bone maturation and the severity of mental deficiency suggest that thyroid failure was present in early life. The presence of endemic cretinism today in Sicily constitutes a strong argument in favour of the immediate introduction of adequate iodine prophylaxis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7320434     DOI: 10.1007/BF03349447

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  19 in total

1.  A radioimmunoassay for thyroxine in unextracted serum.

Authors:  S Filetti; A Galbiati; F Trimarchi; R Vigneri
Journal:  J Nucl Biol Med       Date:  1975 Apr-Jun

2.  Health significance of endemic goitre and related conditions.

Authors:  F W CLEMENTS
Journal:  Monogr Ser World Health Organ       Date:  1960

3.  The effect of varying iodine content on the susceptibility of thyroglobulin to hydrolysis by thyroid acid protease.

Authors:  L Lamas; S H Ingbar
Journal:  Endocrinology       Date:  1978-01       Impact factor: 4.736

4.  Assessment of some methodological aspects of radioimmunoassay of triiodothyronine.

Authors:  A Galbiati; R Malvano; G C Zucchelli
Journal:  J Nucl Biol Med       Date:  1974 Oct-Dec

5.  Endemic cretinism in Idjwi Island (Kivu Lake, Republic of Congo).

Authors:  F Delange; A M Ermans; H L Vis; J B Stanbury
Journal:  J Clin Endocrinol Metab       Date:  1972-06       Impact factor: 5.958

6.  Endemic cretinism in eastern New Guinea.

Authors:  I H Buttfield; B S Hetzel
Journal:  Australas Ann Med       Date:  1969-08

7.  Notes on the anatomical and functional pictures of acute hot thyroid nodes and the relationships between this form and endemic goitre.

Authors:  L Gubetta; F Cottino; A Costa
Journal:  J Nucl Biol Med       Date:  1974 Jan-Mar

8.  A radioimmunoassay for human thyrotropin.

Authors:  R Vigneri; D Papalia; L Motta
Journal:  J Nucl Biol Med       Date:  1969 Oct-Dec

9.  A stable sheep cell preparation for detecing thyroglobulin auto-antibodies and its clinical applications.

Authors:  A J FULTHORPE; I M ROITT; D DONIACH; K COUCHMAN
Journal:  J Clin Pathol       Date:  1961-11       Impact factor: 3.411

10.  A radioimmunoassay for human thyroglobulin: methodology and clinical applications.

Authors:  V Pezzino; P Cozzani; S Filetti; A Galbiati; E Lisi; S Squatrito; R Vigneri
Journal:  Eur J Clin Invest       Date:  1977-12       Impact factor: 4.686

View more
  15 in total

Review 1.  Goiter and iodine deficiency in Europe. The European Thyroid Association report as updated in 1988.

Authors:  R Gutekunst; P C Scriba
Journal:  J Endocrinol Invest       Date:  1989-03       Impact factor: 4.256

Review 2.  Thyroid consequences of Chernobyl accident in the countries of the European Community.

Authors:  J Malone; J Unger; F Delange; R Lagasse; J E Dumont
Journal:  J Endocrinol Invest       Date:  1991-09       Impact factor: 4.256

3.  Longitudinal study on goiter prevalence and goitrogen factors in northeastern Sicily.

Authors:  C Regalbuto; S Squatrito; G L La Rosa; G Cercabene; A Ippolito; P Tita; S Salamone; R Vigneri
Journal:  J Endocrinol Invest       Date:  1996-10       Impact factor: 4.256

4.  Epidemiological survey of goiter and iodine deficiency in Veneto region.

Authors:  F Frigato; D Cerisara; D De Vido; E Garola; M E Girelli; C Insolia; D Nacamulli; L Tatò; A Vianello Dri; B Busnardo
Journal:  J Endocrinol Invest       Date:  1996-12       Impact factor: 4.256

5.  Increased serum thyroglobulin concentrations and impaired thyrotropin response to thyrotropin-releasing hormone in euthyroid subjects with endemic goiter in Sicily: their relation to goiter size and nodularity.

Authors:  F Vermiglio; S Benvenga; R Melluso; S Catalfamo; P Princi; S Battiato; F Consolo; F Trimarchi
Journal:  J Endocrinol Invest       Date:  1986-10       Impact factor: 4.256

6.  Partial beneficial effects of the so called "silent iodine prophylaxis" on iodine deficiency disorders (IDD) in northeastern Sicily endemia.

Authors:  F Vermiglio; M D Finocchiaro; V P Lo Presti; N La Torre; M Nucifora; F Trimarchi
Journal:  J Endocrinol Invest       Date:  1989-02       Impact factor: 4.256

7.  Studies on the goiter endemia in Sicily.

Authors:  R Vigneri
Journal:  J Endocrinol Invest       Date:  1988-12       Impact factor: 4.256

8.  A Spanish laborer with the most severe iodine deficiency disorder.

Authors:  F Trimarchi
Journal:  J Endocrinol Invest       Date:  2018-02-24       Impact factor: 4.256

9.  A congenitally hypothyroid young man (Seated Dwarf, Goya's Studio, 19th century).

Authors:  F Trimarchi; F De Luca
Journal:  J Endocrinol Invest       Date:  2018-01-18       Impact factor: 4.256

10.  Effects of prophylaxis with iodised salt in an area of endemic goitre in north-eastern Sicily.

Authors:  C Regalbuto; G Scollo; G Pandini; R Ferrigno; V Pezzino
Journal:  J Endocrinol Invest       Date:  2009-12-01       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.